Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRK1 known ✓ | P41145 | 1/20 | 0.33 |
| ▸ | KLKB1 known ✓ | P03952 | 2/20 | 0.32 |
| ▸ | GAA known ✓ | P10253 | 2/20 | 0.31 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | PLG | P00747 | 1/20 | 0.40 |
| ▸ | PLAT | P00750 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | F2 | P00734 | 1/20 | 0.34 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.34 |
| ▸ | SYK | P43405 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | F11 | P03951 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL5076171 | 1.00 | LMNA (0.40) | LMNAPLGPLATMAPTF2 | |
| SCHEMBL917427 | 0.99 | LMNA (0.41) | LMNAPLGPLATMAPTF2 | |
| SCHEMBL917430 | 0.99 | LMNA (0.41) | LMNAPLGPLATMAPTF2 | |
| Hydrochloric Acid SCHEMBL10977530 | 0.88 | PLG (0.50) | LMNAPLGPLATF2KLKB1 | |
| Hydrochloric Acid SCHEMBL10973896 | 0.86 | PLG (0.42) | LMNAPLGPLATF2SYK | |
| Hydrochloric Acid SCHEMBL10973889 | 0.86 | PLG (0.42) | LMNAPLGPLATF2SYK | |
| SCHEMBL10973838 | 0.82 | PLG (0.44) | LMNAPLGPLATF2SYK | |
| SCHEMBL10973845 | 0.82 | PLG (0.44) | LMNAPLGPLATF2SYK | |
| SCHEMBL10978935 | 0.81 | PLG (0.46) | LMNAPLGPLATF2TSHR | |
| Hydrochloric Acid SCHEMBL1068668 | 0.80 | PLG (0.52) | LMNAPLGPLATMAPTF2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080171691-A1 | Inhibition of invasive remodelling | LUND LEIF ROGE | 2008-07-17 | — | — | US | claimed |
| US-20050137121-A1 | Inhibiting or abolishing the protein cleaving action of plasmin, and inhibiting or abolishing the protein cleaving action of a murine metalloprotease. | LUND LEIF R (DK) | 2005-06-23 | — | — | US | claimed |
| EP-0942746-B1 | INHIBITION OF INVASIVE REMODELLING | FONDEN TIL FREMME AF EKSPERIME (DK) | 2005-03-16 | — | — | EP | claimed |
| US-20020099004-A1 | Inhibition of invasive remodelling | LUND LEIF ROGE (DK) | 2002-07-25 | — | — | US | claimed |
| US-20080171691-A1 | Inhibition of invasive remodelling | LUND LEIF ROGE | 2008-07-17 | — | — | US | disclosed |
| US-20050137121-A1 | Inhibiting or abolishing the protein cleaving action of plasmin, and inhibiting or abolishing the protein cleaving action of a murine metalloprotease. | LUND LEIF R (DK) | 2005-06-23 | — | — | US | disclosed |
| EP-0942746-B1 | INHIBITION OF INVASIVE REMODELLING | FONDEN TIL FREMME AF EKSPERIME (DK) | 2005-03-16 | — | — | EP | disclosed |
| US-20020099004-A1 | Inhibition of invasive remodelling | LUND LEIF ROGE (DK) | 2002-07-25 | — | — | US | disclosed |
| EP-0942746-A1 | INHIBITION OF INVASIVE REMODELLING | FONDEN TIL FREMME AF EKSPERIMENTEL CANCERFORSKNING (DK) | 1999-09-22 | — | — | EP | disclosed |
| WO-1998024474-A1 | INHIBITION OF INVASIVE REMODELLING | FONDEN TIL FREMME AF EKSPERIMENTEL CANCERFORSKNING (DK) | 1998-06-11 | — | — | WO | disclosed |
| WO-1994015904-A1 | NOVEL PROCESS AND INTERMEDIATES FOR THE PREPARATION OF PRODRUGS | PHARMACIA AB (SE) | 1994-07-21 | — | — | WO | disclosed |
| EP-0079872-B1 | ANTIFIBRINOLYTICALLY ACTIVE COMPOUNDS | KabiVitrum AB (SE) | 1985-03-20 | — | — | EP | disclosed |
| US-4483867-A | ANTIULCER AGENTS, ANTIEDEMIC AGENTS | KABIVITRUM AB (SE) | 1984-11-20 | — | — | US | disclosed |
| EP-0079872-A1 | Antifibrinolytically active compounds | KabiVitrum AB (SE) | 1983-05-25 | — | — | EP | disclosed |